论文部分内容阅读
目的探讨肝动脉插管化疗栓塞术对原发性肝癌的临床治疗效果。方法抽取2013年1月至2016年12月间来我院采用肝动脉插管化疗栓塞术治疗的15例原发性肝癌患者,对其治疗结果进行回顾性分析。结果患者治疗前和治疗1个月后的AFP、AST、γ-GT、TBi L指标存在显著差异;治疗2个月后根据近期疗效评价标准进行评估,总有效率为93.3%;治疗期间不良反应发生率为20.0%。结论肝动脉插管化疗栓塞术治疗原发性肝癌不仅能够明显改善患者的临床症状,提高近期疗效和患者的生活质量,而且操作简便、不良反应发生率低、安全性高,值得临床推广应用。
Objective To investigate the clinical effect of transcatheter arterial chemoembolization on primary liver cancer. Methods Fifteen patients with primary liver cancer treated with transcatheter arterial chemoembolization in our hospital from January 2013 to December 2016 were retrospectively analyzed. Results There were significant differences in AFP, AST, γ-GT and TBi L before treatment and after 1 month of treatment. After 2 months of treatment, the total effective rate was 93.3% according to the evaluation criteria of short-term efficacy. The adverse reactions The incidence was 20.0%. Conclusion Hepatic arterial chemoembolization for primary hepatocellular carcinoma not only can significantly improve the clinical symptoms, improve the short-term efficacy and quality of life of patients, but also easy to operate, low incidence of adverse reactions, high safety and worthy of clinical application.